Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

NCT01103414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Mitoglitazone
DRUG: Mitoglitazone
DRUG: Mitoglitazone
DRUG: Pioglitazone
DRUG: Placebo

Sponsor

Metabolic Solutions Development Company